Cost-effectiveness of mirogabalin for the treatment of post-herpetic neuralgia in Taiwan.

Conclusion: Mirogabalin 30mg, a potent and selective α2δ ligand, is a cost-effective treatment option for PHN in Taiwan, with ICERs below the willingness-to-pay threshold.
PMID: 31971469 [PubMed - as supplied by publisher]

Source: Journal of Medical Economics - January 25, 2020 Category: Health Management Tags: J Med Econ Source Type: research